Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Into the Unknown: Regulatory Perspective on Identifying Optimized Dosages of Oncology Radiopharmaceutical Therapies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 23, 2026
Oncology Drug Development: Challenges of Increasingly Available Therapies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 04, 2026
The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials.
Journal: JNCI cancer spectrum
Published: April 21, 2025
FDA approvals in 2024: new options for patients across cancer types and therapeutic classes.
Journal: Nature reviews. Clinical oncology
Published: April 11, 2025
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2025
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 17, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.
Journal: JCO precision oncology
Published: August 29, 2024
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
Journal: Journal of the National Cancer Institute
Published: June 24, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 30, 2024
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis.
Journal: Journal of the National Cancer Institute
Published: December 21, 2023
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 29, 2023
Last Updated: 09/26/2026